WO2000044306A1 - Biodegradable polymeriprotein based coils for intralumenal implants - Google Patents

Biodegradable polymeriprotein based coils for intralumenal implants Download PDF

Info

Publication number
WO2000044306A1
WO2000044306A1 PCT/US1999/022420 US9922420W WO0044306A1 WO 2000044306 A1 WO2000044306 A1 WO 2000044306A1 US 9922420 W US9922420 W US 9922420W WO 0044306 A1 WO0044306 A1 WO 0044306A1
Authority
WO
WIPO (PCT)
Prior art keywords
coil
biocompatible
protein
growth factor
providing
Prior art date
Application number
PCT/US1999/022420
Other languages
English (en)
French (fr)
Inventor
Yuichi Murayama
Fernando Vinuela
Original Assignee
The Regents Of The University Of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1999/001790 external-priority patent/WO1999044538A1/en
Application filed by The Regents Of The University Of California filed Critical The Regents Of The University Of California
Priority to JP2000595611A priority Critical patent/JP2003524456A/ja
Priority to EP99951622A priority patent/EP1156759A4/en
Priority to AU64026/99A priority patent/AU6402699A/en
Priority to CA002323151A priority patent/CA2323151C/en
Publication of WO2000044306A1 publication Critical patent/WO2000044306A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214—Coils or wires
    • A61B17/1215—Coils or wires comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006—Properties of materials and coating materials
    • A61F2002/30062—(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006—Properties of materials and coating materials
    • A61F2002/3008—Properties of materials and coating materials radio-opaque, e.g. radio-opaque markers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
    • A61F2250/0098—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers

Definitions

  • the invention relates generally to the field of surgical and endovascular interventional instruments and specially to Intraluminal implants for occlusion of vessels or aneurysms.
  • Brain aneurysms are the commonest cause of nontraumatic subarachnoid hemorrhage (SAH) which is a significant life-threatening disease in adults. Annually in North America, the rupture of saccular aneurysms accounts for 25000 new cases of SAH. Microsurgical clipping of an aneurysm has been considered the gold standard for the treatment of this disease. Recently, intravascular treatment of aneurysms has become an accepted alternative technique. With the availability of microcatheters capable of accessing the intracranial circulation it has become possible to obliterate an aneurysm by filling it with soft platinum detachable coils (Guglielmi Detachable Coils; GDC).
  • GDC Global System for Delivery and detachment of platinum coils within an aneurysm.
  • Recent advances in endovascular techniques have proved valuable in the treatment of cerebral saccular aneurysms.
  • GDCs have contributed especially to improvements in the endovascular management of cerebral aneurysms.
  • the size of an aneurysm neck has an important effect on the anatomic results of aneurysm obliteration. It has been reported that in one study complete obliteration of aneurysms was achieved in 85% of small-necked aneurysms and 15% of wide-necked aneurysms.
  • GDCs Guglielmi detachable coils
  • Occlusion coils are used to occlude a site within a body lumen, such as a blood vessel, brain aneurysm, or vascular malformation.
  • the coils are typically placed at a desired site within the lumen by means of a microcatheter.
  • the coils are normally made of a radioopaque, biocompatible metals such as platinum, gold, or tungsten.
  • the coils occlude the aneurysm by posing a physical barrier to blood flow and by promoting thrombus formation.
  • the formation of the neo-endothelium and mature intra-aneurysmal thrombus is necessary prior to subsequent organization and scar formation that, in turn, yields a permanently occluded aneurysm.
  • metallic coils can be insufficiently thrombogenic to promote the establishment of firm and mature thrombus within the aneurysm. They have difficulty in promoting endothelialization across the wide neck of an aneurysm. Therefore, it is advantageous to tightly pack the aneurysm with coils for complete cure of the aneurysms. This may cause a mass effect on adjacent the brain parenchyma or cranial nerves.
  • Bioabsorbable polymers such as polyglycolic acid and polyglycolic/poly-L-lactic acid copolymers, or bioabsorbable proteins, such as collagen and gelatins, have been used to make Intraluminal implants. These bioabsorbable polymers or proteins are also used to provide a the drug delivery vehicle (such as for continuous local delivery of growth factors). It is necessary to modify biological cellular response in preparation for acceleration of wound healing.
  • Coil thrombogenicity was enhanced previously by increasing the surface area of the coils with fabric strands, such as Dacron, and by placing such coils into a thrombin solution. More recently, some investigators have modified the surfaces of platinum coils by coating them with collagen or polyurethane. This has resulted in some advantages, such as an increase in thrombogenicity of these coils.
  • protein coatings on platinum surfaces are usually weak and may be removed easily during the delivery of the coils. Additionally, weakly coated proteins may be washed off by high-velocity arterial flow and may be a potential source of distal thromboemboli.
  • polyurethane coatings in particular also have the disadvantage of producing unfavorable changes in GDC performance, affecting their softness, thinness, smoothness,
  • GDCs and surrounding thrombus within an aneurysm are continuously exposed to and interact with circulating blood at the neck of the aneurysm.
  • Coil compaction resulting from the force of pulsatile arterial blood flow is one of the reasons for incomplete obliteration of aneurysms. When this occurs, there is a potential risk of aneurysm recanalization and (re)rupture.
  • Re- endothelialization and the promotion of wound healing in the aneurysmal sac and across its neck are necessary for complete aneurysm cure.
  • the invention is an intravascular device that modifies either accelerating or decreasing biological cellular response comprising a separable tip or coil comprised at least in part of at least one biocompatible and absorbable polymer or protein, and a placement device associated with the separable coil adapted to dispose the coil into a selected body lumen.
  • the biocompatible and absorbable polymer or protein promotes an intra-aneurysmal inflammatory response and healing of the aneurysms.
  • This device may carry growth factors, such as a vascular endothelial growth factor, a basic fibroblast growth factor or a mixture of several growth factors or cytokines.
  • the separable tip which also need not be a coil, need not be comprised of a polymer or protein, but may be comprised of any material now known or later devised which is biocompatible, absorbable and which promotes an intra-aneurysmal inflammatory response and promotes healing of the aneurysm.
  • the biocompatible and absorbable polymer is in the illustrated embodiment at least one polymer selected from the group consisting of polyglycolic acid, poly ⁇ glycolic acid/poly-L-lactic acid copolymers, polycaprolactive, polyhydroxybutyrate/hydroxyvalerate copolymers, poly-L- lactide, polydioxanone, polycarbonates, and polyanhydrides.
  • the biocompatible and absorbable protein is at least one protein selected from the group consisting of collagen, fibrinogen, fibronectin, vitronectin, laminin, and gelatin.
  • the coil is composed of the biocompatible and absorbable polymer or protein with a radio-opaque material is disposed thereon.
  • the coil is composed of a radio-opaque material, and the biocompatible and absorbable polymer or protein is disposed thereon.
  • the invention is also characterized as a method for forming a thrombus comprising the steps of providing a separable coil comprised at least in part of at least one biocompatible and absorbable polymer or protein and disposing the separable coil into a body lumen including the various combinations and examples described above.
  • the method further of comprises the step of providing the coil with a growth factor, and in particular a vascular endothelial growth factor (VEGF), a basic fibroblast growth factor (bFGF), or other growth factors.
  • a growth factor and in particular a vascular endothelial growth factor (VEGF), a basic fibroblast growth factor (bFGF), or other growth factors.
  • VEGF vascular endothelial growth factor
  • bFGF basic fibroblast growth factor
  • a biodegradable polymer (or protein) coils are used to control thrombosis or accelerate wound healing of the brain aneurysms for which platinum coils sometimes have often proven unsatisfactory.
  • Another aspect of the invention is a method of drug delivery system using biodegradable polymer (or proteins) in the combination with growth factors such as vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) or other growth factors which promote long lasting effect of the wound healing
  • growth factors such as vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) or other growth factors which promote long lasting effect of the wound healing
  • biodegradable coils are useful for treating giant brain aneurysms to prevent the mass effect on the brain parenchyma or cranial nerves by shrinkage of scaring aneurysm.
  • the implants of the invention may be placed within body lumens, e.g., blood vessels, Fallopian tubes, etc., of any mammalian species, including humans.
  • the implant coils are made of biocompatible and absorbable polymers or proteins.
  • bioabsorbable polymers that have been used in the illustrated embodiment to make Intraluminal implants include but are not limited to polyglycolic acid, poly ⁇ gycolic/poly-L-lactic acid copolymers, polycaprolactive, polyhydroxybutyrate /hydroxyvalerate copolymers, poly-L-lactide, polydioxanone, polycarbonates, and polyanhydrides.
  • bioabsorbable proteins that have been used in the illustrated embodiment to make Intraluminal implants include but are not limited to collagen, fibrinogen, fibronectin, vitronectin, laminin and gelatin.
  • the bioabsorbable polymer coils may be coated or mixed with radioopaque materials such as tantalum or platinum.
  • the bioabsorbable polymer or protein itself may be mounted or coated onto coils or wires of metals such as platinum or nitonol.
  • Preferred growth factors for use in the invention are the naturally occurring mammalian angiogenic growth such as VEGF, or b-FGF. Mixtures of such growth factors may also be used if desired.
  • the biodegradable polymer coils of the invention can be placed within the body lumen, vascular system or vessels using procedures well known in the art.
  • the desired site within the vessel is accessed with a catheter.
  • the catheter may be guided to the site by the use of guide wires.
  • the catheter lumen is cleared by removing guide wire.
  • the coils are loaded by means of a pusher wire.
  • the coils may be attached to the distal end of the pusher via a cleavable joint (e.g., a joint that is severable by heat, electrolysis, electrodynamic activation or other means) or a mechanical joint that permits the coil to be detached from the distal end of the pusher wire by mechanical manipulation.
  • the coils may be free and detached from the pusher wire, simply pushed through the catheter and expelled from the distal end of the catheter.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pulmonology (AREA)
  • Materials For Medical Uses (AREA)
  • Surgical Instruments (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)
PCT/US1999/022420 1999-01-27 1999-09-27 Biodegradable polymeriprotein based coils for intralumenal implants WO2000044306A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2000595611A JP2003524456A (ja) 1999-01-27 1999-09-27 内腔移植体として用いる生物分解性重合体タンパク質ベースのコイル
EP99951622A EP1156759A4 (en) 1999-01-27 1999-09-27 BIODEGRADABLE POLYMER PROTEIN-BASED SPIRALS FOR INTRALUMINAL IMPLANTS
AU64026/99A AU6402699A (en) 1999-01-27 1999-09-27 Biodegradable polymeriprotein based coils for intralumenal implants
CA002323151A CA2323151C (en) 1999-01-27 1999-09-27 Biodegradable polymer/protein based coils for intralumenal implants

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
USPCT/US99/01790 1999-01-27
PCT/US1999/001790 WO1999044538A1 (en) 1998-01-27 1999-01-27 Biodegradable polymer/protein based coils for intralumenal implants

Publications (1)

Publication Number Publication Date
WO2000044306A1 true WO2000044306A1 (en) 2000-08-03

Family

ID=22272061

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/022420 WO2000044306A1 (en) 1999-01-27 1999-09-27 Biodegradable polymeriprotein based coils for intralumenal implants

Country Status (5)

Country Link
EP (1) EP1156759A4 (ja)
JP (3) JP2003524456A (ja)
AU (1) AU6402699A (ja)
CA (1) CA2323151C (ja)
WO (1) WO2000044306A1 (ja)

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6368346B1 (en) 1999-06-03 2002-04-09 American Medical Systems, Inc. Bioresorbable stent
WO2002066091A2 (en) 2001-02-16 2002-08-29 The Regents Of The University Of California Bioabsobable polmeric implants and a method of using the same to create occlusions
WO2002089863A1 (en) * 2001-05-04 2002-11-14 Concentric Medical Bioactive polymer vaso-occlusive device
US6585754B2 (en) 2001-05-29 2003-07-01 Scimed Life Systems, Inc. Absorbable implantable vaso-occlusive member
US7314636B2 (en) 2001-06-29 2008-01-01 Medgraft Microtech, Inc. Biodegradable injectable implants containing glycolic acid
US7572288B2 (en) 2001-07-20 2009-08-11 Microvention, Inc. Aneurysm treatment device and method of use
US8715312B2 (en) 2001-07-20 2014-05-06 Microvention, Inc. Aneurysm treatment device and method of use
US8864790B2 (en) 2006-04-17 2014-10-21 Covidien Lp System and method for mechanically positioning intravascular implants
US8876881B2 (en) 2006-10-22 2014-11-04 Idev Technologies, Inc. Devices for stent advancement
US8876880B2 (en) 1999-02-01 2014-11-04 Board Of Regents, The University Of Texas System Plain woven stents
US8966733B2 (en) 2006-10-22 2015-03-03 Idev Technologies, Inc. Secured strand end devices
US9011480B2 (en) 2012-01-20 2015-04-21 Covidien Lp Aneurysm treatment coils
US9023094B2 (en) 2007-06-25 2015-05-05 Microvention, Inc. Self-expanding prosthesis
US9023095B2 (en) 2010-05-27 2015-05-05 Idev Technologies, Inc. Stent delivery system with pusher assembly
US9050095B2 (en) 2004-09-22 2015-06-09 Covidien Lp Medical implant
US9198665B2 (en) 2004-09-22 2015-12-01 Covidien Lp Micro-spiral implantation device
US9289215B2 (en) 2007-03-13 2016-03-22 Covidien Lp Implant including a coil and a stretch-resistant member
US9579104B2 (en) 2011-11-30 2017-02-28 Covidien Lp Positioning and detaching implants
US9622753B2 (en) 2001-07-20 2017-04-18 Microvention, Inc. Aneurysm treatment device and method of use
US9655999B2 (en) 2013-03-12 2017-05-23 Carnegie Mellon University Coated vaso-occlusive device for treatment of aneurysms
US9687245B2 (en) 2012-03-23 2017-06-27 Covidien Lp Occlusive devices and methods of use
US9713475B2 (en) 2014-04-18 2017-07-25 Covidien Lp Embolic medical devices
US10058330B2 (en) 2011-05-11 2018-08-28 Microvention, Inc. Device for occluding a lumen

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011007134A1 (de) 2011-04-11 2012-10-11 Basf Se Verfahren zur Herstellung eines Polyamids durch anionische Polymerisation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891192A (en) * 1997-05-22 1999-04-06 The Regents Of The University Of California Ion-implanted protein-coated intralumenal implants
US5935145A (en) * 1998-02-13 1999-08-10 Target Therapeutics, Inc. Vaso-occlusive device with attached polymeric materials
US6007573A (en) * 1996-09-18 1999-12-28 Microtherapeutics, Inc. Intracranial stent and method of use
US6015424A (en) * 1998-04-28 2000-01-18 Microvention, Inc. Apparatus and method for vascular embolization

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843156A (en) * 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
US4994069A (en) * 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method
US5464650A (en) * 1993-04-26 1995-11-07 Medtronic, Inc. Intravascular stent and method
US5549624A (en) * 1994-06-24 1996-08-27 Target Therapeutics, Inc. Fibered vasooclusion coils
NO962336L (no) * 1995-06-06 1996-12-09 Target Therapeutics Inc Vaso-okklusiv spiral
US5624461A (en) * 1995-06-06 1997-04-29 Target Therapeutics, Inc. Three dimensional in-filling vaso-occlusive coils
US5853418A (en) * 1995-06-30 1998-12-29 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils (II)
DK0754435T3 (da) * 1995-06-30 2000-11-27 Target Therapeutics Inc Strækningsmodstandsdygtige karokklusionsspiraler
CA2186768C (en) * 1995-09-29 2000-12-12 Pete Phong Pham Anatomically shaped vasoocclusive devices
US5830879A (en) * 1995-10-02 1998-11-03 St. Elizabeth's Medical Center Of Boston, Inc. Treatment of vascular injury using vascular endothelial growth factor
JP4355038B2 (ja) * 1997-09-01 2009-10-28 株式会社カネカメディックス 血管塞栓用具
AU2565099A (en) * 1998-01-27 1999-09-20 Regents Of The University Of California, The Biodegradable polymer/protein based coils for intralumenal implants

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007573A (en) * 1996-09-18 1999-12-28 Microtherapeutics, Inc. Intracranial stent and method of use
US5891192A (en) * 1997-05-22 1999-04-06 The Regents Of The University Of California Ion-implanted protein-coated intralumenal implants
US5935145A (en) * 1998-02-13 1999-08-10 Target Therapeutics, Inc. Vaso-occlusive device with attached polymeric materials
US6015424A (en) * 1998-04-28 2000-01-18 Microvention, Inc. Apparatus and method for vascular embolization

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1156759A4 *

Cited By (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8876880B2 (en) 1999-02-01 2014-11-04 Board Of Regents, The University Of Texas System Plain woven stents
US8974516B2 (en) 1999-02-01 2015-03-10 Board Of Regents, The University Of Texas System Plain woven stents
US9925074B2 (en) 1999-02-01 2018-03-27 Board Of Regents, The University Of Texas System Plain woven stents
US6368346B1 (en) 1999-06-03 2002-04-09 American Medical Systems, Inc. Bioresorbable stent
US8388643B2 (en) 1999-09-27 2013-03-05 The Regents Of The University Of California Bioabsorbable polymeric implants and a method of using the same to create occlusions
EP1900382A3 (en) * 2001-02-16 2008-04-02 The Regents of the University of California Bioabsorbable polymeric implants and a method of using the same to create occlusions
WO2002066091A3 (en) * 2001-02-16 2003-04-03 Univ California Bioabsobable polmeric implants and a method of using the same to create occlusions
WO2002066091A2 (en) 2001-02-16 2002-08-29 The Regents Of The University Of California Bioabsobable polmeric implants and a method of using the same to create occlusions
WO2002089863A1 (en) * 2001-05-04 2002-11-14 Concentric Medical Bioactive polymer vaso-occlusive device
US7559933B2 (en) 2001-05-29 2009-07-14 Scimed Life Systems, Inc. Absorbable implantable vaso-occlusive member
US6585754B2 (en) 2001-05-29 2003-07-01 Scimed Life Systems, Inc. Absorbable implantable vaso-occlusive member
US7314636B2 (en) 2001-06-29 2008-01-01 Medgraft Microtech, Inc. Biodegradable injectable implants containing glycolic acid
US7887599B2 (en) 2001-06-29 2011-02-15 Crisoforo Peralta Casares Methods of use of biodegradable injectable implants
US9539122B2 (en) 2001-07-20 2017-01-10 Microvention, Inc. Aneurysm treatment device and method of use
US7572288B2 (en) 2001-07-20 2009-08-11 Microvention, Inc. Aneurysm treatment device and method of use
US8562667B2 (en) 2001-07-20 2013-10-22 Microvention, Inc. Aneurysm treatment device and method of use
US9622753B2 (en) 2001-07-20 2017-04-18 Microvention, Inc. Aneurysm treatment device and method of use
US8715312B2 (en) 2001-07-20 2014-05-06 Microvention, Inc. Aneurysm treatment device and method of use
US9198665B2 (en) 2004-09-22 2015-12-01 Covidien Lp Micro-spiral implantation device
US9050095B2 (en) 2004-09-22 2015-06-09 Covidien Lp Medical implant
US8864790B2 (en) 2006-04-17 2014-10-21 Covidien Lp System and method for mechanically positioning intravascular implants
US8876881B2 (en) 2006-10-22 2014-11-04 Idev Technologies, Inc. Devices for stent advancement
US9149374B2 (en) 2006-10-22 2015-10-06 Idev Technologies, Inc. Methods for manufacturing secured strand end devices
US8966733B2 (en) 2006-10-22 2015-03-03 Idev Technologies, Inc. Secured strand end devices
US9408729B2 (en) 2006-10-22 2016-08-09 Idev Technologies, Inc. Secured strand end devices
US9408730B2 (en) 2006-10-22 2016-08-09 Idev Technologies, Inc. Secured strand end devices
US9895242B2 (en) 2006-10-22 2018-02-20 Idev Technologies, Inc. Secured strand end devices
US9289215B2 (en) 2007-03-13 2016-03-22 Covidien Lp Implant including a coil and a stretch-resistant member
US9023094B2 (en) 2007-06-25 2015-05-05 Microvention, Inc. Self-expanding prosthesis
US9023095B2 (en) 2010-05-27 2015-05-05 Idev Technologies, Inc. Stent delivery system with pusher assembly
US10058330B2 (en) 2011-05-11 2018-08-28 Microvention, Inc. Device for occluding a lumen
US9579104B2 (en) 2011-11-30 2017-02-28 Covidien Lp Positioning and detaching implants
US10335155B2 (en) 2011-11-30 2019-07-02 Covidien Lp Positioning and detaching implants
US9011480B2 (en) 2012-01-20 2015-04-21 Covidien Lp Aneurysm treatment coils
US10893868B2 (en) 2012-01-20 2021-01-19 Covidien Lp Aneurysm treatment coils
US9687245B2 (en) 2012-03-23 2017-06-27 Covidien Lp Occlusive devices and methods of use
US9655999B2 (en) 2013-03-12 2017-05-23 Carnegie Mellon University Coated vaso-occlusive device for treatment of aneurysms
US10034966B2 (en) 2013-03-12 2018-07-31 Carnegie Mellon University Coated vaso-occlusive device and methods for treatment of aneurysms
US9713475B2 (en) 2014-04-18 2017-07-25 Covidien Lp Embolic medical devices

Also Published As

Publication number Publication date
CA2323151C (en) 2007-04-10
CA2323151A1 (en) 2000-08-03
JP2006021052A (ja) 2006-01-26
EP1156759A1 (en) 2001-11-28
JP2004223268A (ja) 2004-08-12
EP1156759A4 (en) 2002-11-20
JP2003524456A (ja) 2003-08-19
JP4751661B2 (ja) 2011-08-17
AU6402699A (en) 2000-08-18

Similar Documents

Publication Publication Date Title
US6423085B1 (en) Biodegradable polymer coils for intraluminal implants
CA2323151C (en) Biodegradable polymer/protein based coils for intralumenal implants
JP4630525B2 (ja) 生体吸収性ポリマー移植体による血管内装置
ES2391763T3 (es) Dispositivo de embolización
US6113629A (en) Hydrogel for the therapeutic treatment of aneurysms
US7309345B2 (en) Method and system for delivering an implant utilizing a lumen reducing member
US8075585B2 (en) Device and method for treatment of a vascular defect
US7572246B2 (en) Stretch resistant therapeutic device
JP4856339B2 (ja) ヒドロゲルからなる血管塞栓材及びそれを使用した治療方法
US20070078480A1 (en) Self-expanding biodegradable or water-soluble vaso-occlusive devices
JP2006506171A (ja) ナノファイバでできた塞栓装置
JP2010012282A (ja) 吸収性移植可能血管閉塞部材
WO2004069058A1 (ja) 血管塞栓用デバイス
EP1543783A1 (en) Activatable bioactive implantable medical device and method of use

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref country code: AU

Ref document number: 1999 64026

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2323151

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1999951622

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 595611

Kind code of ref document: A

Format of ref document f/p: F

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWP Wipo information: published in national office

Ref document number: 1999951622

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642